272 related articles for article (PubMed ID: 20659059)
1. Health outcomes associated with methamphetamine use among young people: a systematic review.
Marshall BD; Werb D
Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
[No Abstract] [Full Text] [Related]
3. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
[TBL] [Abstract][Full Text] [Related]
4. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
[TBL] [Abstract][Full Text] [Related]
5. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
Plüddemann A; Dada S; Parry CD; Kader R; Parker JS; Temmingh H; van Heerden S; de Clercq C; Lewis I
Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):45-9. PubMed ID: 23417636
[TBL] [Abstract][Full Text] [Related]
6. Sexually transmitted infection prevalence and related risk factors among heterosexual male methamphetamine users in China.
Liu D; Jiang Z; Xiu C; Li Z; Song Q; Wang Z
Int J STD AIDS; 2017 Oct; 28(12):1208-1214. PubMed ID: 28178893
[TBL] [Abstract][Full Text] [Related]
7. Personality traits and mental health states of methamphetamine-dependent and methamphetamine non-using MSM.
Solomon TM; Kiang MV; Halkitis PN; Moeller RW; Pappas MK
Addict Behav; 2010 Feb; 35(2):161-3. PubMed ID: 19786324
[TBL] [Abstract][Full Text] [Related]
8. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
Griffiths P; Mravcik V; Lopez D; Klempova D
Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
[TBL] [Abstract][Full Text] [Related]
9. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
[TBL] [Abstract][Full Text] [Related]
10. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
[TBL] [Abstract][Full Text] [Related]
12. The relationship between methamphetamine use and increased dental disease.
Shetty V; Mooney LJ; Zigler CM; Belin TR; Murphy D; Rawson R
J Am Dent Assoc; 2010 Mar; 141(3):307-18. PubMed ID: 20194387
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults.
Han B; Compton WM; Jones CM; Einstein EB; Volkow ND
JAMA Psychiatry; 2021 Dec; 78(12):1329-1342. PubMed ID: 34550301
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers.
Beyrer C; Razak MH; Jittiwutikarn J; Suriyanon V; Vongchak T; Srirak N; Kawichai S; Tovanabutra S; Rungruengthanakit K; Sawanpanyalert P; Sripaipan T; Celentano DD
Int J STD AIDS; 2004 Oct; 15(10):697-704. PubMed ID: 15479508
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of risk factors for methamphetamine-associated psychosis.
Arunogiri S; Foulds JA; McKetin R; Lubman DI
Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
[TBL] [Abstract][Full Text] [Related]
16. Psychotic symptoms in methamphetamine psychotic in-patients.
Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
[TBL] [Abstract][Full Text] [Related]
17. Soda Consumption Among Methamphetamine Users in the USA: Impact on Oral Health.
Murphy DA; Harrell L; Fintzy R; Vitero S; Gutierrez A; Shetty V
Oral Health Prev Dent; 2016; 14(3):227-34. PubMed ID: 26870851
[TBL] [Abstract][Full Text] [Related]
18. Major physical and psychological harms of methamphetamine use.
Darke S; Kaye S; McKetin R; Duflou J
Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606
[TBL] [Abstract][Full Text] [Related]
19. Investigating the sequential patterns of methamphetamine use initiation in Iran.
Sarani EM; Ahmadi J; Oji B; Mahi-Birjand M; Bagheri N; Bazrafshan A; Manshadi MD; Yaghoubi S; Dezhkam A; Khatami M; Abdollahpour-Alitappeh M
Subst Abuse Treat Prev Policy; 2020 Jul; 15(1):52. PubMed ID: 32727512
[TBL] [Abstract][Full Text] [Related]
20. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
